This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan PSAP staining in paraffin sections with the IHC-validated antibody at 2–5 μg/ml (datasheet A00937-1). Use the granular cytoplasmic tissue pattern to assess staining and consider PSAP secretion when interpreting signal (HPA tissue IHC; UniProt).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Granular cytoplasm in tissue sections (HPA tissue IHC) | |
| Staining pattern | Granular cytoplasm in adipocytes and glandular cells (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A00937-1) | |
| Positive control | Adipose tissue+4 more · see all | |
| Negative control | None in HPA (detected in all 45 tissues); use no-primary + isotype controls |
| Fixation | Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A00937-1) | |
| Caveat | Secreted PSAP may contribute extracellular signal (UniProt) | |
| Regulation | Low tissue specificity; no regulator specified (HPA tissue IHC; UniProt) | |
| Isoform / epitope | 3 isoforms; cleavage into saposins affects epitope coverage (UniProt) |
The catalog antibody has a datasheet IHC-P protocol (datasheet: A00937-1). The published IHC methods below provide sample-specific retrieval, staining and detection conditions (cited PMC articles).
| Sample | Paraffin-embedded human thyroid papillary carcinoma tissue; fixative not specified (datasheet A00937-1) |
| Fixation | Image fixative and duration unreported (datasheet A00937-1); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A00937-1); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A00937-1) |
| Primary antibody | Rabbit anti-PSAP, 2-5 μg/ml (datasheet A00937-1) |
| Primary incubation | Overnight at 4 °C (datasheet A00937-1) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A00937-1) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | PSAP-positive staining in adipocytes of adipose tissue (HPA tissue IHC: High). HPA tissue profile: Granular cytoplasmic expression in all tissues. No signal in the no-primary control. |
PSAP should show granular cytoplasmic staining in cells across tissues (HPA: Supported; granular cytoplasmic expression in all tissues). High staining is reported in adipocytes, glandular cells, hematopoietic cells, respiratory epithelial cells and glia (HPA: tissue IHC). Its lysosomal location supports an intracellular punctate pattern; PSAP is also secreted and has no transmembrane segment (UniProt P07602: location and topology).
| Granular cytoplasmic staining in expected cells, including adipocytes or glandular cells. | This matches the reported tissue pattern (HPA: granular cytoplasmic expression in all tissues; High in adipocytes and glandular cells). Score cellular intensity and distribution separately (general IHC practice). |
| Strong, predominantly nuclear staining with little cytoplasmic granularity. | That compartment conflicts with the supported vesicular pattern (HPA: ICC-IF vesicles) and lysosomal location (UniProt P07602). Consider detection artefact before calling it PSAP. |
| Staining confined to a cell type that does not match the expected pattern in the examined tissue. | Check the tissue-specific reference first (HPA: tissue IHC). Cross-reactivity or endogenous detection activity is possible, but staining alone cannot distinguish them (general IHC practice). |
| Diffuse colour across cells and surrounding tissue obscures granules. | The result cannot be scored reliably against the granular cytoplasmic reference (HPA: tissue IHC). Background from antibody binding or detection chemistry is possible (general IHC practice). |
| No detectable signal in an otherwise interpretable adrenal gland or appendix section. | Both have High glandular-cell staining in HPA tissue IHC. Check assay performance before inferring biological absence; HPA staining does not establish a fixation effect. |
| Compartment and secretion | PSAP is lysosomal and secreted, with no transmembrane segment (UniProt P07602). Interpret extracellular colour cautiously alongside cellular granules; secretion alone cannot validate a deposit. |
| Precursor processing | Prosaposin is cleaved into saposins A–D (UniProt P07602: processing). The recognized form depends on an antibody's epitope; no epitope is supplied here. |
| Glycosylation | Five glycosylation sites are annotated (UniProt P07602: residues 80, 101, 215, 332, 426). This record gives no target-specific prediction for antigen retrieval or fixation sensitivity. |
| Isoforms and antibody validation | Three isoforms are annotated (UniProt P07602). HPA004426 and CAB004647 have Supported IHC status (HPA: antibodies); that status does not establish identical isoform recognition. |
| IF/ICC Q&A: What should fluorescence show? | Expect vesicular signal (HPA: ICC-IF, supported), consistent with lysosomal PSAP (UniProt P07602). ICC-IF images exist for A-431, U-251MG and U2OS (HPA: subcellular). |
| Situation | Likely cause | Next action |
|---|---|---|
| Known-positive tissue lacks granular signal. | Assay failure is possible when expected High cells are blank (HPA: adrenal and appendix glandular cells). | Review the catalog antibody's IHC-P instructions, retrieval conditions and detection controls (general IHC practice); target-specific fixation sensitivity is unreported. |
| Nuclei dominate the stain. | The pattern conflicts with vesicular localisation (HPA: ICC-IF) and lysosomal localisation (UniProt P07602). | Check a no-primary control and inspect counterstain or detection artefacts before assigning PSAP positivity (general IHC practice). |
| Unexpected cell types stain strongly. | Cross-reactivity or endogenous detection activity may contribute (general IHC practice); PSAP is broadly expressed (HPA: tissue IHC). | Compare the exact cell type with HPA tissue images, then assess no-primary and detection controls (HPA: tissue IHC; general IHC practice). |
| Diffuse background hides cellular granules. | Nonspecific binding or detection background can obscure the expected pattern (general IHC practice; HPA: granular cytoplasmic expression). | Review blocking, antibody dilution, washes and chromogen development using appropriate controls (general IHC practice). |
| Extracellular colour appears without clear cell-associated granules. | PSAP can be secreted (UniProt P07602), but extracellular colour alone does not establish specific staining. | Compare nearby cellular staining and a no-primary control; report the extracellular finding separately (general IHC practice). |
| IF/ICC appears diffuse instead of vesicular. | Diffuse fluorescence differs from the supported vesicular reference (HPA: ICC-IF subcellular summary). | Check background controls, focus and permeabilisation conditions before interpreting the signal (general IF practice); use the separate IF/ICC guide for workflow. |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Supported — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | High | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | High | Protein (IHC) | HPA → |
| Appendix | Glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | High | Protein (IHC) | HPA → |
| Breast | Glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| None in HPA: PSAP is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead. | ||||
Troubleshoot PSAP staining by checking retrieval, tissue processing, cellular pattern, antibody epitope and detection controls (datasheet A00937-1; HPA tissue IHC; UniProt P07602).
Anti-PSAP A00937-1 has human paraffin-section IHC, A549 ICC/IF, and human thyroid-cancer IF examples (catalog image captions); M00937 is listed for human IHC (catalog applications/reactivity).
A00937-1 has IHC images from human thyroid papillary carcinoma and tonsil paraffin sections, plus IF images from A549 cells and a human thyroid-cancer paraffin section (catalog image captions). M00937 is listed for human IHC, but has no IHC image or documented sample type in the payload (catalog applications/reactivity; IHC image captions).
Which to pick: For tissue IHC, choose A00937-1 when image-backed human paraffin-section evidence matters; its IHC captions report EDTA retrieval and 2 μg/ml primary antibody, but do not report the fixative (A00937-1 IHC image captions). For IF/ICC, choose A00937-1 because its application list and images cover both; M00937 is a rabbit monoclonal, clone 24P28, listed for IHC without an IF/ICC application or image (catalog applications; catalog clone; image captions). Neither SKU has documented cross-species reactivity in this payload (catalog reactivity: Human for both).